GCRC CEO Mike Robinson Named To Scientific Committee for Int'l Conference on Innovations and Advances in Cancer Research
Mike Robinson, Nanobles Corporations CEO, is a cannabinoid medicine researcher that founded the Global Cannabinoid Research Center in 2018
Mike Robinson, the Corporations CEO, is a cannabinoid medicine researcher that was just named to the Top 100 Most Influential People In Cannabis for 2021 by High Times Magazine.
David Uhalley and Mike Robinson, the Nanobles Corporate Team
Mike Robinson, the Corporations CEO with his daughter Genevieve, was once a cannabis compassion provider that's well known for beating multiple cancers using cannabis oils
The CEO for The NANO Group, Mike Robinson, leads the Global Cannabinoid Research Center (GCRC), a world renowned cannabinoid medicine researcher and educator
"We must share as much knowledge as possible with Clinicians from around the world that are intrigued by the breakthroughs in Cannabinoid Medicine, the future potential in therapies from plant extracts, and the current outcomes of the self-treatment reported by patients, which would include me now that I'm in a 4th Cancer battle," explained the Researcher that's been very public about his fight against Non-Hodgkin's Lymphoma in 2023.
"I support Mike in the work he does in this regard," stated Nanobles C.O.O. David Uhalley," our corporation has grown from a single trademark to now engulfing his Global Cannabinoid Research Center in a merger last year, and that has created a snowball effect of momentum as the R&D continues. More creations are worked on daily to help the world. At the same time, Mike continues to share as much as he can with clinicians and others in healthcare as our entity has a mission to help the world, not just ourselves."
Mike Robinson is well known for his work in the field of Cannabis Compassion in helping kids with disabilities gain access to cannabis oils. He met his future wife and adoptive daughters Genevieve and Sydney, whom he met while traveling and helping Genevieve - who has severe Autism.
Before he entered the world of Cannabis Compassion and then into Cannabinoid Medicine R&D, Robinson spent nearly two decades as a Civil Rights Lobbyist for kids in special education, representing pro bono throughout the United States. Now, he educates free of charge and has done nearly three dozen continued medical education symposiums and conferences.
But, this conference is unique AdvCancer 2023 provides a platform for experts to exchange ideas, present their research findings, and collaborate on new initiatives to improve cancer outcomes worldwide. It aims to facilitate the development of new cancer prevention and treatment strategies, improve the quality of life for cancer patients, and reduce the burden of cancer on individuals, families, and communities. Participants will have the opportunity to network with colleagues, learn about emerging trends and technologies, and hear from leaders in the field.
The conference will feature keynote lectures, plenary sessions, symposia, poster presentations, and opportunities for interactive discussions and workshops. Topics will range from the molecular mechanisms of cancer to the challenges of cancer care in resource-limited settings, focusing on promoting equity and access to care for all.
Scientific Sessions
Advances in precision medicine for cancer treatment
Innovative technologies for cancer diagnosis and monitoring
Cancer immunotherapy: novel approaches and clinical trials
Cancer metabolism and therapeutic targeting
Emerging trends in cancer stem cells research
Biomarker Discovery and application in cancer treatment
Targeted therapy resistance and overcoming strategies
Artificial Intelligence and machine learning in cancer research
Cancer genetics and Epigenetics
Novel drug development for cancer treatment
Oncology nursing: innovations and challenges
Cancer prevention and lifestyle modifications
Palliative care for cancer patients: challenges and advancements
Social and ethical issues in cancer research and Treatment
Mike Robinson
Global Cannabinoid Research Center
+1 8056179539
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
